Cure Research for Kidney Dialysis
Latest Treatments for Kidney Dialysis
Some of the more recent treatments for Kidney Dialysis include:
Cure Research discussion for Kidney Dialysis:
The National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
through its Division of Kidney, Urologic, and Hematologic Diseases,
supports several programs and studies devoted to improving treatment
for patients with progressive kidney disease and end-stage kidney
failure (sometimes called end-stage renal disease, or ESRD),
including patients on hemodialysis:
- The End-Stage Renal Disease Program. This program
promotes research to reduce medical problems from bone, blood,
nervous system, metabolic, gastrointestinal, cardiovascular, and
endocrine abnormalities in end-stage kidney failure and to improve
the effectiveness of dialysis and transplantation. The research
focuses on reuse of hemodialysis membranes and on using
alternative dialyzer sterilization methods; on devising more
efficient, biocompatible membranes; on refining high-flux
hemodialysis; and on developing criteria for dialysis adequacy.
The program also seeks to increase kidney graft and patient
survival and to maximize quality of life.
- The HEMO Study. This multicenter clinical trial is
testing whether a higher hemodialysis dose and/or high-flux
membranes will reduce patient mortality (death) and morbidity
(medical problems).
- The U.S. Renal Data System (USRDS).This national data
system collects, analyzes, and distributes information about the
use of dialysis and transplantation to treat kidney failure in the
United States. The USRDS is funded directly by the NIDDK in
conjunction with the Health Care Financing Administration. The
USRDS publishes an Annual Data Report,
which characterizes the total population of people being treated
for kidney failure; reports on incidence, prevalence, mortality
rates, and trends over time; and develops data on the effects of
various treatment modalities. The report also helps identify
problems and opportunities for more focused special studies of
renal research issues.
- The Hemodialysis Vascular Access Clinical Trials
Consortium will conduct a series of multicenter, randomized,
placebo-controlled clinical trials of drug therapies to reduce the
failure and complication rate of arteriovenous grafts and fistulas
in hemodialysis. Recently developed antithrombotic agents and
drugs to inhibit cytokines may be evaluated in these large
clinical trials.
(Source: excerpt from
Anemia in Kidney Disease and Dialysis: NIDDK)
Kidney Dialysis Treatment: Book Excerpts
Evidence Based Medicine Research for Kidney Dialysis
Medical research papers related to Kidney Dialysis include:
Click here to find more evidence-based articles on the TRIP Database
As little as 40 years ago, a diagnosis of total kidney failure meant that death would soon follow. But thanks to major advances in medical...
One of the most important lifesaving advances for kidney failure, dialysis, was invented during World War II, but not widely available until the...
Ice cream, beaches, and.... kidney stones? It's a little known fact, but kidney stones are much more common in the summer. Why is this the case?...
Not all kidney stones are alike. Learn about the different types, and how each kind of stone brings its own specific problems.
See full list of 10 related videos
» Next page: Deaths from Kidney Dialysis
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
